packageAvalglucosidaseAlfa

avalglucosidase alfa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Avalglucosidase alfa is an enzyme medication used to treat glycogen storage disease type II (Pompe disease). It is authorised in the European Union and is an approved medicine, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q107693067 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:avalglucosidase alfa
ATC codes:A16AB22
DrugBank:DB16099
Wikidata:Q107693067
molar mass:124000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown